| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Profit before tax | -0.1 | -0.0 |
| Net income | -0.1 | -0.0 |
| EPS (diluted, $ a share) | $-0.45 | $-0.20 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
10-Q filed with the SEC, OTC: TRFA. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Trafalgar International, Inc.: key numbers
- Share price
- $0.8095Close, Nov 13
- Market cap
- $161K
- Shares outstanding
- 199.15KLatest SEC cover page
- Sector
- Life Sciences
- Industry
- Pharmaceutical PreparationsSIC 2834
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Trafalgar International, Inc.
All →Trafalgar International Other 8-K Filing
Trafalgar International, Inc. approved the amendment and restatement of its Articles of Incorporation to modify its authorized capital stock and the rights of its Series A and Series B Preferred Stock. The company will file a Preliminary Information Statement on Schedule 14C to notify shareholders of these actions, which were approved via written consent in lieu of a meeting.
Trafalgar International Leadership Change
Trafalgar International appointed Carlos Septién as Chief Executive Officer and to the Board of Directors, succeeding Porfirio Sanchez Talavera who resigned as CEO but remains Chairman. Mr. Septién previously served as the company's Chief Operating Officer and brings over 45 years of experience in the Mexican banking and financial services sectors. The transition follows a recent corporate name change and aligns with the company's strategy to focus on acquisitions in the financial services and technology sectors.